Steroids reduce local inflammatory mediator secretion and mucosal permeability in collagenous colitis patients
- PMID: 17109497
- PMCID: PMC4087346
- DOI: 10.3748/wjg.v12.i43.7012
Steroids reduce local inflammatory mediator secretion and mucosal permeability in collagenous colitis patients
Abstract
Aim: To study the effect of oral steroids upon clinical response and rectal mucosa secretion of eosinophil cationic protein (ECP), myeloperoxidase (MPO), basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and albumin in patients with collagenous colitis (CC).
Methods: A segmental perfusion technique was used to collect perfusates from rectum of CC patients once before and twice (one and four weeks) after the start of steroid treatment. Clinical data was monitored and ECP, MPO, bFGF, VEGF and albumin concentrations were analyzed by immunochemical methods in perfusates and in serum.
Results: Steroids reduced the number of bowel movements by more than five times within one week and all patients reported improved subjective well-being at wk 1 and 4. At the same time, the median concentrations of ECP, bFGF, VEGF and albumin in rectal perfusates decreased significantly. MPO values were above the detection limit in only 3 patients before treatment and in none during treatment. VEGF, bFGF, ECP and albumin concentrations correlated with each other with the exception of ECP and albumin. A decrease of serum ECP and VEGF concentrations was also seen even if the overtime reduction was not significant.
Conclusion: Oral steroid treatment in CC patients induced a simultaneous reduction of bowel movements and rectal release of ECP, bFGF, VEGF and albumin, suggesting that these polypeptides and increased mucosal permeability are important components of the pathophysiology in collagenous colitis.
Figures


Similar articles
-
Fecal eosinophil cationic protein as a marker of active disease and treatment outcome in collagenous colitis: a pilot study.Scand J Gastroenterol. 2011 Jul;46(7-8):849-54. doi: 10.3109/00365521.2011.571707. Epub 2011 May 11. Scand J Gastroenterol. 2011. PMID: 21557718 Clinical Trial.
-
Evidence of local eosinophil activation and altered mucosal permeability in collagenous colitis.Dig Dis Sci. 2001 Apr;46(4):888-97. doi: 10.1023/a:1010781224158. Dig Dis Sci. 2001. PMID: 11330429
-
Intestinal mucosal secretion of basic fibroblast growth factor in patients with ulcerative colitis.Scand J Gastroenterol. 2000 Apr;35(4):408-12. doi: 10.1080/003655200750023985. Scand J Gastroenterol. 2000. PMID: 10831265
-
Mucosal secretion and expression of basic fibroblast growth factor in patients with collagenous colitis.Am J Gastroenterol. 2003 Sep;98(9):2011-7. doi: 10.1111/j.1572-0241.2003.07634.x. Am J Gastroenterol. 2003. PMID: 14499780
-
Elevated fecal levels of eosinophil granule proteins predict collagenous colitis in patients referred to colonoscopy due to chronic non-bloody diarrhea.Scand J Gastroenterol. 2016 Jul;51(7):835-41. doi: 10.3109/00365521.2016.1141432. Epub 2016 Feb 7. Scand J Gastroenterol. 2016. PMID: 26854205
Cited by
-
Hypothesis: Caco-2 cell rotational 3D mechanogenomic turing patterns have clinical implications to colon crypts.J Cell Mol Med. 2018 Dec;22(12):6380-6385. doi: 10.1111/jcmm.13853. Epub 2018 Sep 25. J Cell Mol Med. 2018. PMID: 30255651 Free PMC article.
-
Microscopic colitis.Curr Treat Options Gastroenterol. 2007 Jun;10(3):231-6. doi: 10.1007/s11938-007-0016-0. Curr Treat Options Gastroenterol. 2007. PMID: 17547861
-
Increased fecal levels of chromogranin A, chromogranin B, and secretoneurin in collagenous colitis.Inflammation. 2013 Aug;36(4):855-61. doi: 10.1007/s10753-013-9612-4. Inflammation. 2013. PMID: 23423580
-
Downstream exposure to growth factors causes elevated velocity and dilation in arteriolar networks.J Vasc Res. 2011;48(1):11-22. doi: 10.1159/000317396. Epub 2010 Jul 6. J Vasc Res. 2011. PMID: 20606467 Free PMC article.
-
Emerging Role of Myeloperoxidase in the Prognosis of Nephrotic Syndrome Patients Before and After Steroid Therapy.J Clin Diagn Res. 2015 Jul;9(7):BC01-4. doi: 10.7860/JCDR/2015/12532.6222. Epub 2015 Jul 1. J Clin Diagn Res. 2015. PMID: 26393116 Free PMC article.
References
-
- Jawhari A, Talbot IC. Microscopic, lymphocytic and collagenous colitis. Histopathology. 1996;29:101–110. - PubMed
-
- Bogomoletz WV. Collagenous, microscopic and lymphocytic colitis. An evolving concept. Virchows Arch. 1994;424:573–579. - PubMed
-
- Jessurun J, Yardley JH, Giardiello FM, Hamilton SR, Bayless TM. Chronic colitis with thickening of the subepithelial collagen layer (collagenous colitis): histopathologic findings in 15 patients. Hum Pathol. 1987;18:839–848. - PubMed
-
- Aigner T, Neureiter D, Müller S, Küspert G, Belke J, Kirchner T. Extracellular matrix composition and gene expression in collagenous colitis. Gastroenterology. 1997;113:136–143. - PubMed
-
- Tagkalidis P, Bhathal P, Gibson P. Microscopic colitis. J Gastroenterol Hepatol. 2002;17:236–248. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous